Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.130
+0.030 (0.73%)
At close: Jan 16, 2026, 4:00 PM EST
4.110
-0.020 (-0.48%)
After-hours: Jan 16, 2026, 5:16 PM EST
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,956,181
Profits / Employee
-$1,183,919
Market Cap
22.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - |
| Jun 30, 2024 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEUP News
- 5 weeks ago - Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria's Director Nominees - GlobeNewsWire
- 6 weeks ago - Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium - GlobeNewsWire
- 6 weeks ago - Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - GlobeNewsWire
- 7 weeks ago - Neuphoria Therapeutics Inc. Sends Letter to Stockholders - GlobeNewsWire
- 2 months ago - Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value - GlobeNewsWire
- 2 months ago - Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process - GlobeNewsWire
- 3 months ago - PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 3 months ago - Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder - GlobeNewsWire